Myomo - Stock Price History | MYO
Historical daily share price chart and data for Myomo since 2020 adjusted for splits. The latest closing stock price for Myomo as of February 21, 2020 is 6.87.
- The all-time high Myomo stock closing price was 24.50 on February 05, 2020.
- The Myomo 52-week high stock price is 40.00, which is 482.2% above the current share price.
- The Myomo 52-week low stock price is 0.26, which is 96.2% below the current share price.
- The average Myomo stock price for the last 52 weeks is 1.35.
| Myomo Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 0.9287 | 1.5500 | 1.7500 | 0.2999 | 0.3008 | -79.11% |
| 2018 | 2.8421 | 3.6500 | 5.4000 | 1.4400 | 1.4400 | -61.60% |
| 2017 | 6.6563 | 7.4000 | 19.3100 | 2.2100 | 3.7500 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.004B | $0.002B |
| Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $154.651B | 26.99 |
| Medtronic (MDT) | Ireland | $151.838B | 20.41 |
| Stryker (SYK) | United States | $84.017B | 27.16 |
| Boston Scientific (BSX) | United States | $59.405B | 26.81 |
| Baxter (BAX) | United States | $47.313B | 28.69 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.638B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $32.373B | 20.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $31.917B | 0.00 |
| Coloplast (CLPBY) | Denmark | $30.078B | 46.42 |
| Terumo (TRUMY) | Japan | $25.672B | 0.00 |
| ResMed (RMD) | United States | $25.146B | 43.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $22.065B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $18.195B | 0.00 |
| Insulet (PODD) | United States | $13.125B | 624.44 |
| Bio-Rad Laboratories (BIO) | United States | $11.989B | 56.01 |
| Perrigo (PRGO) | Ireland | $8.148B | 15.19 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.644B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.537B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.161B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.118B | 20.47 |
| Haemonetics (HAE) | United States | $5.950B | 36.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| ICU Medical (ICUI) | United States | $4.460B | 29.07 |
| Envista Holdings (NVST) | United States | $4.366B | 0.00 |
| NuVasive (NUVA) | United States | $3.920B | 30.31 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.883B | 0.00 |
| Neogen (NEOG) | United States | $3.798B | 63.21 |
| Agios Pharmaceuticals (AGIO) | United States | $3.639B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.493B | 0.00 |
| Quidel (QDEL) | United States | $3.325B | 29.19 |
| National Vision Holdings (EYE) | United States | $2.844B | 64.20 |
| Aurora Cannabis (ACB) | Canada | $1.952B | 0.00 |
| AtriCure (ATRC) | United States | $1.559B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.555B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.417B | 0.00 |
| InMode (INMD) | Israel | $1.247B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.194B | 0.00 |
| Aphria (APHA) | $1.105B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.088B | 21.52 |
| PetIQ (PETQ) | United States | $0.983B | 23.97 |
| VAREX IMAGING (VREX) | United States | $0.966B | 20.08 |
| Cerus (CERS) | United States | $0.820B | 0.00 |
| Quanterix (QTRX) | United States | $0.782B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.713B | 27.31 |
| Omeros (OMER) | United States | $0.697B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.650B | 16.25 |
| LeMaitre Vascular (LMAT) | United States | $0.607B | 34.52 |
| MacroGenics (MGNX) | United States | $0.561B | 0.00 |
| Surmodics (SRDX) | United States | $0.504B | 58.00 |
| Organigram Holdings (OGI) | Canada | $0.438B | 0.00 |
| Owens & Minor (OMI) | United States | $0.437B | 16.16 |
| HEXO (HEXO) | $0.401B | 0.00 | |
| Zynex (ZYXI) | United States | $0.388B | 43.93 |
| OraSure Technologies (OSUR) | United States | $0.376B | 46.85 |
| Utah Medical Products (UTMD) | United States | $0.361B | 25.64 |
| Meridian Bioscience (VIVO) | United States | $0.332B | 13.35 |
| BioLife Solutions (BLFS) | United States | $0.320B | 130.25 |
| Female Health (VERU) | United States | $0.296B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.286B | 0.00 |
| Bovie Medical (APYX) | United States | $0.260B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.213B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.212B | 22.36 |
| Rockwell Medical (RMTI) | United States | $0.205B | 0.00 |
| Vapotherm (VAPO) | United States | $0.197B | 0.00 |
| United Health Products (UEEC) | United States | $0.185B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.172B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.171B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.132B | 9.58 |
| Surface Oncology (SURF) | United States | $0.107B | 0.00 |
| Chimerix (CMRX) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.080B | 0.00 |
| United-Guardian (UG) | United States | $0.074B | 18.80 |
| Nephros (NEPH) | United States | $0.071B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.023B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.015B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
| Valeritas Holdings (VLRXQ) | United States | $0.001B | 0.00 |
